MOMENTA PHARMACEUTICALS INC 4
4 · MOMENTA PHARMACEUTICALS INC · Filed Dec 12, 2013
Insider Transaction Report
Form 4
Franken Michael
President, Biosimilars Busines
Transactions
- Award
Stock Option (Right to Buy)
2013-12-10$17.23/sh+46,788$806,157→ 70,000 totalExercise: $17.23From: 2014-12-10Exp: 2023-12-10→ Common Stock (46,788 underlying) - Award
Common Stock
2013-12-10+25,000→ 25,000 total - Award
Stock Option (Right to Buy)
2013-12-10$17.23/sh+23,212$399,943→ 23,212 totalExercise: $17.23From: 2014-12-10Exp: 2023-12-10→ Common Stock (23,212 underlying)
Footnotes (2)
- [F1]Represents 25,000 shares of restricted common stock, $0.0001 par value per share, awarded pursuant to the Company's 2013 Stock Incentive Plan, and subject to a restricted stock agreement to be entered between the Company and Mr. Franken. Pursuant to the restricted stock agreement, 25% of the shares of restricted Common Stock shall vest on December 10, 2014 and an additional 6.25% of the shares of restricted Common Stock shall vest at the end of each three month period thereafter.
- [F2]Represents options granted by the issuer pursuant to the issuer's 2013 Stock Incentive Plan. Subject to certain criteria such options vest as to 25% of the shares on December 10, 2014 and as to an additional 6.25% of the shares at the end of each successive three month period following December 10, 2014.